SPC Financial Inc’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-4,900
Closed -$690K 125
2019
Q2
$690K Sell
4,900
-195
-4% -$26.9K 0.14% 76
2019
Q1
$769K Buy
5,095
+3,120
+158% +$449K 0.16% 72
2018
Q4
$245K Sell
1,975
-3,280
-62% -$449K 0.07% 109
2018
Q3
$833K Buy
+5,255
New +$795K 0.17% 71
2016
Q1
Sell
-13,250
Closed -$1.5M 107
2015
Q4
$1.5M Buy
13,250
+820
+7% +$88.3K 0.59% 39
2015
Q3
$1.26M Sell
12,430
-150
-1% -$17.8K 0.54% 46
2015
Q2
$1.56M Sell
12,580
-310
-2% -$37.4K 0.44% 50
2015
Q1
$1.52M Buy
12,890
+300
+2% +$33.9K 0.42% 54
2014
Q4
$1.28M Buy
12,590
+2,370
+23% +$231K 0.37% 52
2014
Q3
$938K Sell
10,220
-60
-0.6% -$5.21K 0.27% 62
2014
Q2
$846K Sell
10,280
-35
-0.3% -$2.68K 0.24% 66
2014
Q1
$791K Buy
10,315
+1,790
+21% +$140K 0.24% 65
2013
Q4
$590K Buy
+8,525
New +$559K 0.18% 73

Other funds holding FBT

SPC Financial Inc's FBT Position: Q3 2019 in Review

SPC Financial Inc sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2019, closing a stake of 4,900 shares — an estimated $690K sold.

SPC Financial Inc first reported a position in FBT in Q4 2013 and held it in 13 quarters. The position peaked at $1.56M in Q2 2015. 188 funds tracked by Wall St. Rank hold FBT as of Q3 2019.

  • SPC Financial Inc reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2019 after selling out during the quarter.
  • SPC Financial Inc sold 4,900 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2019, an estimated $690K.
  • SPC Financial Inc first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2013 and held it in 13 quarters.
  • SPC Financial Inc's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.56M in Q2 2015.
  • 188 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2019.

Based on SPC Financial Inc's 13F filing for Q3 2019, filed 18 Oct 2019.